- Home
- MPV vs SERA Comparison
MPV vs SERA Comparison
Compare MPV & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPV
- SERA
- Stock Information
- Founded
- MPV 1988
- SERA 2008
- Country
- MPV United States
- SERA United States
- Employees
- MPV N/A
- SERA N/A
- Industry
- MPV Finance Companies
- SERA Precision Instruments
- Sector
- MPV Finance
- SERA Health Care
- Exchange
- MPV Nasdaq
- SERA Nasdaq
- Market Cap
- MPV 181.3M
- SERA 208.7M
- IPO Year
- MPV N/A
- SERA 2021
- Fundamental
- Price
- MPV $16.90
- SERA $4.12
- Analyst Decision
- MPV
- SERA
- Analyst Count
- MPV 0
- SERA 0
- Target Price
- MPV N/A
- SERA N/A
- AVG Volume (30 Days)
- MPV 25.2K
- SERA 150.9K
- Earning Date
- MPV 01-01-0001
- SERA 03-19-2025
- Dividend Yield
- MPV 8.71%
- SERA N/A
- EPS Growth
- MPV N/A
- SERA N/A
- EPS
- MPV 1.71
- SERA N/A
- Revenue
- MPV N/A
- SERA $94,000.00
- Revenue This Year
- MPV N/A
- SERA N/A
- Revenue Next Year
- MPV N/A
- SERA $3,081.82
- P/E Ratio
- MPV $9.35
- SERA N/A
- Revenue Growth
- MPV N/A
- SERA N/A
- 52 Week Low
- MPV $11.18
- SERA $3.84
- 52 Week High
- MPV $16.42
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- MPV 48.99
- SERA 31.08
- Support Level
- MPV $17.03
- SERA $3.89
- Resistance Level
- MPV $17.77
- SERA $4.46
- Average True Range (ATR)
- MPV 0.40
- SERA 0.43
- MACD
- MPV 0.05
- SERA -0.00
- Stochastic Oscillator
- MPV 50.85
- SERA 10.22
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.